We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ultra-Fast Cameras Used To Visualize Molecular Activity

By LabMedica International staff writers
Posted on 23 Dec 2008
Scientists in Munich and Boston have been working with new three-dimensional (3D) imaging systems that use ultra-fast cameras to capture high resolution images of the molecular activity in laboratory mice engineered to develop lung cancer. More...
With additional evaluation, the scientists reported the same approach could be used to study cancer in people.

The research was led by Dr. Vasilis Ntziachristos, director of the Institute for Biological and Medical Imaging at the Helmholtz Center (Munich, Germany), and Dr. Mark Niedre, assistant professor of electrical and computer engineering at Northeastern University (Boston, MA, USA). The technology involved required a sophisticated use of light. According to Dr. Niedre, they solved the problems associated with traditional infrared-imaging technology, resulting is a clearer image of molecular markers of inflammation and other lung disorders.

The inventory of genes and proteins associated with cancer and other diseases is growing rapidly: early in November 2008, for instance, scientists reported sequencing the whole genome of a cancer cell for the first time. Molecular imaging technology puts this data in context by allowing scientists to see biologic molecules in action inside diseased cells and tissues. Now, researchers have devised a molecular imaging technique that uses near-infrared light peer deeper into the body.

Fluorescent-protein tags can be generated to target nearly any biologic protein, be it an enzyme that helps cancer cells advance through surrounding tissue or a marker of arthritic inflammation. However, their use has been limited to shallow tissues in humans or to small animals. The markers are triggered by, and emit near-infrared or infrared light, which scatters in the tissue; the more tissue the light has to penetrate, the blurrier the images become. A new 3D near-infrared imaging system utilizes ultra-fast cameras to capture light that has not scattered. The technology been used to create clearer, higher-resolution images of the molecular workings of lung cancer in mice, and with further development, it might be used to study disease in thicker tissues and in humans.

This progress, according to the scientists, should quickly provide researchers with an inside look at how cancer metastasizes inside an animal. The scientists are now trying to determine the precise molecular mechanism that occurs as cancer spreads from one tumor site to another.

Related Links:
Helmholtz Center
Northeastern University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.